Updated:
Furong Capital
Furong Capital is a venture capital firm based in China, established by the Research Institute of Fudan University in Ningbo. It has made 54 investments,...
Furong Capital
Furong Capital is a venture capital firm based in China, established by the Research Institute of Fudan University in Ningbo. It has made 54 investments, including a Seed VC investment in Prodegre on February 25, 2026. The firm has 2 portfolio exits, with TYK Medicines exiting on August 20, 2024.
General information
Firm type
Private Equity
Year founded
2013
Location
Region
Asia
Country
China
City
Shanghai
Corporate office
Shanghai, China
Sector focus
Frequently asked questions
What is Furong Capital's investment focus?
Furong Capital targets Chinese companies across the full venture-to-growth lifecycle, including seed, startup, early-stage, expansion/late-stage, growth equity, and PIPE transactions (per public reference data). The firm has not publicly disclosed sector-specific preferences or exclusions.
Is Furong Capital affiliated with Fudan University?
The firm's website domain is fudannb.com, strongly implying an affiliation with Fudan University — one of China's premier institutions — but no official statement from the university or the firm confirms a formal partnership. The firm may leverage alumni networks for deal sourcing.
Does Furong Capital disclose its AUM or fund performance?
Furong Capital has not published AUM, committed capital, or fund performance data in any English-language public record. Its financial metrics remain undisclosed.
What is known about Furong Capital's team?
No named investment professionals or key personnel are found in publicly available sources. The firm has no public LinkedIn presence and does not list a team on its website.
Has Furong Capital completed any notable deals?
No specific portfolio companies or transactional details are recorded in English-language media or industry databases accessible to the public. The firm's deal flow is opaque.
Does Furong Capital focus on early-stage investment only?
No — the firm's stated strategy spans early-stage (seed, startup) through expansion, late-stage, growth, and PIPE transactions, indicating a flexibility uncommon among single-stage firms. However, no fund vehicles or stage-specific mandates are confirmed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: